Sabinsa, the multi-national health science company known for providing sustainable natural, well-researched ingredients, announces Dr. K Srinivasa Reddy as Sami-Sabinsa Group Director of Quality & Regulatory. Dr. Srinivasa will drive the Quality initiatives across the organization and its subsidiaries, including oversight of quality control, quality assurance, microbiology, clinical trials, and regulatory compliance for formulation and ingredients. He is based at the Sami-Sabinsa Group corporate office in Bangalore, India.

Dr. Srinivasa, who earned his Ph.D. in Chemistry from Bundelkhand University, has over 21 years of industry experience, including a previous stint on the Sami Labs science team. Prior to re-joining the Sami-Sabinsa Group, he was working as Director of Quality at Omni Active Health Care Technologies. Other professional experience includes Vimta Life Sciences - Preclinical Facility, Piramal Life Sciences, Apotex Research India Pvt Ltd, GVK Biosciences, and Aurobindo Pharma Research Centre. He is an active member of professional organizations including the Drug Information Association and the Society of Quality Assurance.

“Not only does Dr. Srinivasa have vast clinical research experience, but he has also demonstrated a deep commitment to quality throughout his career, so I am pleased to have him on the team to ensure that Sabinsa’s portfolio of ingredients continues to meet the highest standards, and are supported by studies that establish safety and efficacy,” said Global CEO & Managing Director Shaheen Majeed. “His regulatory experience will be important in planning studies that fit within the regulatory framework of the many regions in which Sabinsa’s products are sold.”

“Sabinsa’s long history of providing superior material to customers is one to be proud of, and I am pleased to have a role in ensuring that reputation continues to be deserved,” said Dr. Srinivasa. “I’m glad to be back here as part of the family where I began my journey.”